Vaxart Reports Positive 12-Month Phase 2b Safety Data
SOUTH SAN FRANCISCO, Calif., July 6, 2026 Vaxart, Inc. has announced positive topline 12-month safety results from the approximately...
COVID-19
Advertisement
Invivyd Receives FDA EUA Termination Notice for PEMGARDA
NEW HAVEN, Conn., July 6, 2026 Invivyd announced that the U.S. Food and Drug Administration (FDA) has issued a...
Visby Medical Receives FDA Clearance for First Multi-Virus Home PCR
SAN JOSE, California, July 2, 2026 Visby Medical has received U.S. Food and Drug Administration (FDA) clearance for the...
Sunshine Biopharma Secures U.S. Patent for Novel Coronavirus Therapy
FORT LAUDERDALE, Fla., May 29, 2026 Sunshine Biopharma announced that the United States Patent and Trademark Office has issued...
Advertisement
